Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Clinical Epigenetics|May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancerWenji Yan, Kongming Wu, James G Herman, et al.
Disease Markers|July 9, 2021
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-CancerShiyun Chen, Miaomiao Gou, Huan Yan, et al.
DNA and Cell Biology|August 23, 2017
CD19loCD27hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal CancerHui Mao, Fei Pan, Zhiyong Wu, et al.
Biomed Research International|June 17, 2022
Identification of Small Nucleolar RNA SNORD60 as a Potential Biomarker and Its Clinical Significance in Lung AdenocarcinomaHongwei Zhou, Yibing Yao, Yan Li, et al.
International Immunopharmacology|May 31, 2017
Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammationHui Mao, Fei Pan, Zhiyong Wu, et al.
Frontiers in Genetics|February 4, 2022
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A)Quanli Han, Si Liu, Zhi Cui, et al.
Frontiers in Oncology|March 7, 2022
A Composite Biomarker of Derived Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 AntibodiesYuting Pan, Haiyan Si, Guochao Deng, et al.
Clinical and Translational Medicine|December 1, 2023
The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating studyLei Huang, Hui Yang, Kaidi Chen, et al.
European Journal of Radiology Open|January 14, 2025
Deep learning radiomics analysis for prediction of survival in patients with unresectable gastric cancer receiving immunotherapyMiaomiao Gou, Hongtao Zhang, Niansong Qian, et al.
Frontiers in Oncology|July 5, 2021
PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based AnalysisMiaomiao Gou, Yong Zhang, Tiee Liu, et al.
Pageof 11